Author: Judy Quinn

NYGC Scientists Awarded Dept. of Defense Grant to Advance Understanding of Gene Expression in ALS-Frontotemporal Dementia Clinical Spectrum

NEW YORK, NY (December 23, 2021) — Scientists at the New York Genome Center (NYGC) have received an Amyotrophic Lateral Sclerosis Research Program Clinical Development Award from the Department of Defense’s Congressionally Directed Medical Research Programs to lead a project focused on performing single nucleus RNA sequencing of postmortem tissues from patients in the ALS-frontotemporal dementia […]

Dr. Hemali Phatnani Awarded NIH Grant to Build 3D Atlas To Map “Senescent” Cells and Probe Their Role in Human Aging and Disease

NEW YORK, NY (October 20, 2021) — The National Institutes of Health (NIH) has selected Hemali Phatnani, PhD, Core Faculty Member and Director, Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), as a grantee in its Cellular Senescence Network (SenNet) program. Dr. Phatnani also holds a joint appointment as Assistant Professor of […]

Powerful Technique Details Brain Tumors’ Formidable Resiliency

NEW YORK, NY (September 30, 2021) — A team led by researchers at Weill Cornell Medicine, Harvard Medical School and the New York Genome Center has profiled in unprecedented detail thousands of individual cells sampled from patients’ brain tumors. The findings, along with the methods developed to obtain those findings, represent a significant advance in cancer research, and […]